205
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Phenytoin Cream for the Treatment of Sciatic Pain: Clinical Effects and Theoretical Considerations: Case Report

Pages 99-105 | Received 02 Dec 2019, Accepted 18 Feb 2020, Published online: 02 Mar 2020

References

  • Cook CE, Taylor J, Wright A, Milosavljevic S, Goode A, Whitford M. Risk factors for first time incidence sciatica: a systematic review. Physiother Res Int. 2014;19(2):65–78. doi:10.1002/pri.1572.
  • Ropper AH, Zafonte RD. Sciatica. N Engl J Med. 2015;372(13):1240–1248. doi:10.1056/NEJMra1410151.
  • Stafford MA, Peng P, Hill DA. Sciatica: a review of history, epidemiology, pathogenesis, and the role of epidural steroid injection in management. Br J Anaesth. 2007;99(4):461–473. doi:10.1093/bja/aem238.
  • Lewis RA, Williams NH, Sutton AJ, Burton K, Din NU, Matar HE, Hendry M, Phillips CJ, Nafees S, Fitzsimmons D, et al. Comparative clinical effectiveness of management strategies for sciatica: systematic review and network meta-analyses. Spine J. 2015;15(6):1461–1477. doi:10.1016/j.spinee.2013.08.049.
  • Urits I, Peck J, Orhurhu MS, Wolf J, Patel R, Orhurhu V, Kaye AD, Viswanath O. Off-label antidepressant use for treatment and management of chronic pain: evolving understanding and comprehensive review. Curr Pain Headache Rep. 2019;23(9):019–0803. doi:10.1007/s11916-019-0803-z.
  • Ryan C, Roberts L. Life on hold’: The lived experience of radicular symptoms. A qualitative, interpretative inquiry. Musculoskelet Sci Pract. 2019;39:51–57. doi:10.1016/j.msksp.2018.11.005.
  • Kopsky DJ, Keppel Hesselink JM. Topical phenytoin for the treatment of neuropathic pain. JPR. 2017;Volume 10:469–473. doi:10.2147/JPR.S129749.
  • Kopsky DJ, Keppel Hesselink JM. Phenytoin cream for the treatment of neuropathic pain: case series. Pharmaceuticals. 2018;11(2):53. doi:10.3390/ph11020053.
  • Kopsky DJ, Keppel Hesselink JM. Single-blind placebo-controlled response test with phenytoin 10% cream in neuropathic pain patients. Pharmaceuticals. 2018;11(4):122. doi:10.3390/ph11040122.
  • Cheng JK, Ji RR. Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res. 2008;33(10):1970–1978. doi:10.1007/s11064-008-9711-z.
  • Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG. Small-fibre neuropathies–advances in diagnosis, pathophysiology and management. Nat Rev Neurol. 2012;8(7):369–379. doi:10.1038/nrneurol.2012.97.
  • Loeser JD, Treede RD. The Kyoto protocol of IASP basic pain terminology. Pain. 2008;137(3):473–477. doi:10.1016/j.pain.2008.04.025.
  • Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic pain: central vs. peripheral mechanisms. Curr Pain Headache Rep. 2017;21(6):017–0629. doi:10.1007/s11916-017-0629-5.
  • Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926. doi:10.1016/j.jpain.2009.06.012.
  • Forstenpointner J, Naleschinski D, Wasner G, Hullemann P, Binder A, Baron R. Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic pain. Pain Rep. 2019;4(1)Jan-Feb.:e709. doi:10.1097/PR9.0000000000000709.
  • Nijs J, Paul van Wilgen C, Van Oosterwijck J, van Ittersum M, Meeus M. How to explain central sensitization to patients with ‘unexplained’ chronic musculoskeletal pain: practice guidelines. Man Ther. 2011;16(5):413–418. doi:10.1016/j.math.2011.04.005.
  • Black JA, Liu S, Waxman SG. Sodium channel activity modulates multiple functions in microglia. Glia. 2009;57(10):1072–1081. doi:10.1002/glia.20830.
  • Black JA, Liu S, Hains BC, Saab CY, Waxman SG. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain. 2006;129(12):3196–3208. doi:10.1093/brain/awl216.
  • Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013;111(1):26–37. doi:10.1093/bja/aet128.
  • Keppel Hesselink JM, Kopsky DJ. Phenytoin: neuroprotection or neurotoxicity?. Neurol Sci. 2017;38(6):1137–1141. doi:10.1007/s10072-017-2993-7.
  • Lewis WG, Rhodes RS. Systemic absorption of topical phenytoin sodium. Ann Pharmacother. 1994;28(7-8):961–961. doi:10.1177/106002809402800723.
  • Anstead GM, Hart LM, Sunahara JF, Liter ME. Phenytoin in wound healing. Ann Pharmacother. 1996;30(7-8):768–775. doi:10.1177/106002809603000712.
  • Hsieh CH, Jeng SF, Lu TH, Yang JC, Hsieh MW, Chen YC, Rau CS. Correlation between skin biopsy with quantification of intraepidermal nerve fiber and the severity of sciatic nerve traction injury in rats. J Trauma. 2009;66(3):737–742. doi:10.1097/TA.0b013e3181623332.
  • Ma W, Bisby MA. Calcitonin gene-related peptide, substance P and protein gene product 9.5 immunoreactive axonal fibers in the rat footpad skin following partial sciatic nerve injuries. J Neurocytol. 2000;29(4):249–262.
  • Taylor AM, Osikowicz M, Ribeiro-da-Silva A. Consequences of the ablation of nonpeptidergic afferents in an animal model of trigeminal neuropathic pain. Pain. 2012;153(6):1311–1319. doi:10.1016/j.pain.2012.03.023.
  • Bechakra M, Schuttenhelm BN, Pederzani T, van Doorn PA, de Zeeuw CI, Jongen J. The reduction of intraepidermal P2X3 nerve fiber density correlates with behavioral hyperalgesia in a rat model of nerve injury-induced pain. J Comp Neurol. 2017;525(17):3757–3768. doi:10.1002/cne.24302.
  • Duarte JM, D’Onofrio HM, Rolon JI, Bertotti AC. [The impairment of A-delta fibers in median nerve compression at the wrist, using the cutaneous silent period. Medicina. 2016;76(4):219–222.
  • Wongmek A, Shin S, Zhou L. Skin biopsy in assessing meralgia paresthetica. Muscle Nerve. 2016;53(4):641–643. doi:10.1002/mus.25044.
  • Schmid AB, Bland JD, Bhat MA, Bennett DL. The relationship of nerve fibre pathology to sensory function in entrapment neuropathy. Brain. 2014;137(12):3186–3199. doi:10.1093/brain/awu288.
  • Clarke C, Christensen C, Curran MWT, Chan KM. Assessment of small sensory fiber function across the spectrum of severity in carpal tunnel syndrome patients. Muscle Nerve. 2017;56(4):814–816. doi:10.1002/mus.25592.
  • Rice FL, Castel D, Ruggiero E, Dockum M, Houk G, Sabbag I, Albrecht PJ, Meilin S. Human-like cutaneous neuropathologies associated with a porcine model of peripheral neuritis: a translational platform for neuropathic pain. Neurobiol Pain. 2019;5:100021. doi:10.1016/j.ynpai.2018.07.002.
  • Keppel Hesselink JM, Kopsky DJ, Bhaskar AK. Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics. JPR. 2017;10:1–8. doi:10.2147/JPR.S122765.
  • Russell AL, Keppel Hesselink JM. Topical phenytoin in a case of severe fibromyalgia: ex juvantibus proof for fibromyalgia as a localized non-length dependent small fiber neuropathy. J Arch Med Case Rep Case Study. 2019;1(1):1–2. doi:10.31579/26415143/Jamcrcs.2019/003.
  • Keppel Hesselink JM. Fibromyalgia as a localized non-length dependent small fiber neuropathy, responding to topical phenytoin. Med J Clin Trials Case Stud. 2019;3(2):0002. doi:10.23880/mjccs-16000213.
  • Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol. 2019: Sept 9. doi:10.1001/jamaneurol.2019.2917.
  • Zhao P, Barr TP, Hou Q, Dib-Hajj SD, Black JA, Albrecht PJ, Petersen K, Eisenberg E, Wymer JP, Rice FL, et al. Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain. Pain. 2008;139(1):90–105. doi:10.1016/j.pain.2008.03.016.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.